Taiwan Advanced Nanotech Inc. (TPEX:6797)

Market Cap	470.20M -25.2%
Revenue (ttm)	154.37M -21.9%
Net Income	-226.61M
EPS	-7.41
Shares Out	30.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	67,447
Open	15.55
Previous Close	15.30
Day's Range	15.00 - 16.35
52-Week Range	12.55 - 20.70
Beta	0.44
RSI	58.98
Earnings Date	Apr 20, 2026

About Taiwan Advanced Nanotech

Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan Ci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6797

Financial Performance

In 2025, Taiwan Advanced Nanotech's revenue was 154.37 million, a decrease of -21.87% compared to the previous year's 197.59 million. Losses were -226.61 million, 18.9% more than in 2024.